Feb 01, 2017 12:43 pm UTC| Business
ABO-102, the leading clinical gene therapy program for Sanfilippo syndrome type A patients, has demonstrated central nervous system (CNS) and peripheral organ disease biopotencyFirst high dose cohort patient is enrolled,...
Cambrex to Announce Fourth Quarter and Full Year 2016 Financial Results on February 3, 2017
Feb 01, 2017 12:35 pm UTC| Business
EAST RUTHERFORD, N.J., Feb. 01, 2017 -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that fourth quarter and...
Monro Muffler Brake, Inc. Announces Third Quarter Fiscal 2017 Financial Results
Feb 01, 2017 12:30 pm UTC| Business
~ Third Quarter Sales Increased 21% to a Record $288.3 Million, Comparable Store Sales Increased 2.3% ~~ Record Third Quarter EPS Increased 15% to $.53, in Line with Company Guidance ~~ Signs Definitive Agreement to...
Marinus Appoints Michael R. Dougherty to its Board of Directors
Feb 01, 2017 12:30 pm UTC| Business
RADNOR, Pa., Feb. 01, 2017 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today...
The Madison Square Garden Company Partners With TAO Group
Feb 01, 2017 12:30 pm UTC| Business
MSG Acquires 62.5% Interest in New Entity; TAO Group’s Management Retains Remaining Stake ...
Feb 01, 2017 12:30 pm UTC| Business
SAN JOSE, Calif., Feb. 01, 2017 -- FinalCode, Inc., today announced the immediate global availability of the newest release of its persistent, file-centric information rights management (IRM) solution that protects...
Caladrius Biosciences to Present at Upcoming February Conferences
Feb 01, 2017 12:30 pm UTC| Business
BASKING RIDGE, N.J., Feb. 01, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining a select therapeutic development pipeline with an industry-leading...